Team Up to Advance Bioelectronics

The Alliance for Advancing Bioelectronic Medicine (AABM) aims to play a unique convening role for the industry, mobilizing patients, physicians, and other stakeholders to advocate for the field, as well as to engage new audiences such as policy makers, investors, media, and the general public. MD+DI recently spoke with Barry Keenan, vice president of engineering at BioSig Technologies, a company that is one of the initial supporters of the AABM, about the growth and potential of the bioelectronic medicine market. When asked why the bioelectronic market is important in healthcare, Keenan said that bioelectronic medicine has the potential to provide immediate relief for patients suffering from a number of chronic illnesses, without the side effects typically associated with drug therapy. “Many people believe it will replace a number of pharmacotherapies,” he said. “Bioelectronic medicine can treat locally by modulating parts of the central and peripheral nervous system—whereas with drug therapy, chemicals are released into the body that become systemic right away and can have intolerable side effects.” Groups are also exploring bioelectronics in other innovative ways, he noted. For example, Keenan mentioned that there is currently research going on that could use bioelectronics to prevent type 1 diabetes. “This exciting research is at the early preclinical sta...
Source: MDDI - Category: Medical Devices Tags: Electronics Source Type: news

Related Links:

ConclusionThere was a negative correlation between cost of care and glycemic control. Lower cost of care was associated with high burden of psychosocial illness and poor quality of life.
Source: Clinical Epidemiology and Global Health - Category: Epidemiology Source Type: research
CONCLUSIONS: There has been a marked reduction in microvascular complications in Waikato youth and young adults with type 1 diabetes, but the reasons for the reduction are not clear given there has been no significant improvements in glycaemic control. PMID: 32078599 [PubMed - in process]
Source: New Zealand Medical Journal - Category: General Medicine Tags: N Z Med J Source Type: research
Conclusion: Changes in the choroid may occur before the development of diabetic retinopathy and seem to progress with increasing diabetes mellitus duration despite the absence of diabetic retinopathy and without associated retina thickening. Choroidal thickness could be valuable for screening in diabetic children.
Source: RETINA - Category: Opthalmology Tags: Original Study Source Type: research
Conclusion Applying diabetes treatment information from the National Health and Nutrition Examination Survey, as formulated in our treatment-based algorithm, may better identify type 1 and type 2 diabetes cases and thus prevent the specific biases imposed by conventional approaches which include the age of diabetes diagnosis as an initial criterion for diabetes type classification.
Source: Cardiovascular Endocrinology - Category: Cardiology Tags: Original Articles Source Type: research
Publication date: Available online 21 February 2020Source: Life SciencesAuthor(s): Yu-pu Liu, Shui-jin Shao, Hai-dong GuoAbstractDiabetic peripheral neuropathy (DPN) is a common complication of diabetes mellitus that affects approximately half of patients with diabetes. Current treatment regimens cannot treat DPN effectively. Schwann cells (SCs) are very sensitive to glucose concentration and insulin, and closely associated with the occurrence and development of type 1 diabetic mellitus (T1DM) and DPN. Apoptosis of SCs is induced by hyperglycemia and is involved in the pathogenesis of DPN. This review considers the patholo...
Source: Life Sciences - Category: Biology Source Type: research
No abstract available
Source: Nursing - Category: Nursing Tags: Department: COMMUNITY CARE Source Type: research
Condition:   Type 1 Diabetes Intervention:   Sponsor:   Jannet Svensson Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Type1diabetes Intervention:   Behavioral: Residential camp Sponsor:   University of Texas Southwestern Medical Center Enrolling by invitation
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Type 1 Diabetes Intervention:   Sponsor:   Jannet Svensson Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Type1diabetes Intervention:   Behavioral: Residential camp Sponsor:   University of Texas Southwestern Medical Center Enrolling by invitation
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Chemistry | Diabetes | Diabetes Type 1 | Endocrinology | Eyes | Medical Devices | Men